CGTK has been beaten down from over $20/share months ago and has now flatbased and has a Large GAP up to fill! Should be coming out with a few PR's soon of 5-6 drugs in the pipeline. A possible doubler.
ELN is now over $7.10/share, up from $3/share. Another beaten down biotech. from bad news on the drug front. Was $27/share just weeks ago.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.